OR WAIT null SECS
August 26, 2022
Watson-Marlow and Franz Ziel GmbH have launched a new integrated solution to fast-track cell, gene, and biological therapies.
ChargePoint Technology has acquired single-use container company PuroVaso.
August 24, 2022
Anthony Fauci announced that he plans to step down as Director of the National Institute of Allergy and Infectious Diseases in December 2022.
Aerie to be purchased by Alcon after recently bringing two glaucoma drugs to market.
August 23, 2022
NICE has recommended the use of Tavneos (avacopan) in combination with rituximab or cyclophosphamide regimen.
Kapruvia (difelikefalin) has been granted approval by Swissmedic as a treatment for moderate-to-severe pruritis associated with CKD.
The European Commission (EC) has approved Celltrion Healthcare's Vegzelma (CT-P16), a biosimilar to bevacizumab referencing Avastin.
The latest CPHI report has been published, predicting that a significant shift in outsourcing strategies is being experienced globally.
EMA has accepted the marketing authorization application for an oral fixed-dose combination treatment as an initial treatment for adults with AML.
August 22, 2022
Grand River Aseptic Manufacturing has completed phase II of its facility expansion with the installation of two new sterile filling lines.